Cancer therapy clinical trials in Vietnam are expanding as the country builds research capacity and access to advanced treatments. These studies enable patients to receive cutting-edge care while contributing to data that can improve cancer outcomes across the region.
For international sponsors and local institutions, Vietnam offers a growing patient population, evolving regulatory frameworks, and increasing collaboration with global centers. Understanding how trials operate locally helps stakeholders design studies that are ethical, efficient, and impactful.
Overview of Clinical Trials Landscape
Clinical research infrastructure in Vietnam has strengthened over the past decade through partnerships with academic hospitals and multinational organizations. Key features of the current landscape include centralized ethics review, growing site capabilities, and more patient-friendly consent processes.
Trial Registration and Regulatory Requirements
Mandatory Registries and Approvals
Trials must be registered on a national public registry and approved by the Ministry of Health and local ethics committees. Documentation typically includes protocol, informed consent forms, and investigator brochures in Vietnamese.
Patient Recruitment and Retention
Referral Networks and Community Engagement
Major referral centers rely on multidisciplinary tumor boards to identify eligible patients. Community outreach and nurse navigators help reduce screening failures and support adherence during follow-up visits.
Safety Monitoring and Ethics Oversight
Data Monitoring and Adverse Event Reporting
Independent data monitoring committees review safety signals periodically. Serious adverse events are reported promptly to regulators, and protocols incorporate clear stopping rules and unblinding procedures.
| Trial Phase | Therapeutic Area Focus | Key Eligibility Emphasis | Average Enrollment Duration |
|---|---|---|---|
| I | Solid Tumors, Hematologic Malignancies | Dose Escalation, Safety, Pharmacokinetics | 6–18 months |
| II | Lung Cancer, Breast Cancer, Gastrointestinal Cancers | Biomarker-driven Selection, Progression-Free Survival | 12–24 months |
| III | Colorectal Cancer, Hepatocellular Carcinoma | Comparison with Standard Care, Overall Survival | 24–36 months |
Quality of Life and Patient Support
Symptom Monitoring and Ancillary Services
Trials increasingly incorporate patient-reported outcomes and supportive care interventions. Nutritional counseling, pain management, and mental health services are often integrated to maintain quality of life during therapy.
Future Directions and Collaboration Opportunities
Vietnam is expanding precision oncology through genomic profiling and international partnerships. Strengthening biobanking, training sites, and long-term outcome tracking will support higher-quality evidence generation and broader patient access to innovative therapies. Key priorities include building multidisciplinary teams, enhancing pharmacovigilance, and aligning with global standards for protocol design and reporting.
- Verify trial registration and regulatory approvals before enrollment.
- Confirm biomarker testing and inclusion criteria with the study team.
- Clarify financial responsibilities, travel support, and follow-up commitments.
- Engage with patient navigators to manage appointments and supportive care needs.
- Plan long-term monitoring and survivorship care with the local care team.
FAQ
Reader questions
How do I find cancer therapy clinical trials in Vietnam for a specific cancer type?
Contact specialized centers such as Vietnam National Cancer Hospital or university-affiliated hospitals, and check the national clinical trial registry with disease-specific filters.
What are the eligibility criteria that most commonly exclude patients from trials in Vietnam?
Strict organ function thresholds, prior therapies, and limited biomarker testing can limit participation; discussing these with the study team early helps assess suitability.
Are travel and lodging expenses covered for participants in clinical trials in Vietnam?
Coverage varies by sponsor; some trials provide partial or full reimbursement for local transport and accommodations, but patients should confirm details during consent.
How is data privacy handled for international collaborators in Vietnamese clinical trials?
Data sharing agreements follow national regulations, with de-identified datasets often required for cross-border research and storage on secure servers approved by ethics committees.